All Stories

  1. Targeting CXCR1/2 Does Not Improve Insulin Secretion After Pancreatic Islet Transplantation: A Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial in Type 1 Diabetes
  2. The impact of proinflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes
  3. Pharmacological Targeting of GLUT1 to Control Autoreactive T Cell Responses
  4. Selective local irradiation improves islet engraftment and survival in intra–bone marrow islet transplantation
  5. Islets for Research: Nothing Is Perfect, but We Can Do Better
  6. CCL 2/ MCP ‐1 and CXCL 12/ SDF ‐1 blockade by L‐aptamers improve pancreatic islet engraftment and survival in mouse
  7. Human pancreatic islet three-dimensional chromatin architecture provides insights into the genetics of type 2 diabetes
  8. Low-Carb and Ketogenic Diets in Type 1 and Type 2 Diabetes
  9. Glucose metabolism during tumorigenesis in the genetic mouse model of pancreatic cancer
  10. Biofabrication of a vascularized islet organ for type 1 diabetes
  11. Islet Allotransplantation in the Bone Marrow of Patients With Type 1 Diabetes
  12. Inhibition of Eph/ephrin interaction with the small molecule UniPR500 improves glucose tolerance in healthy and insulin-resistant mice
  13. Diabetes‐free survival after extended distal pancreatectomy and islet auto transplantation for benign or borderline/malignant lesions of the pancreas
  14. Measurement of Autoantibodies to Gastric H+,K+-ATPase (ATP4A/B) Using a Luciferase Immunoprecipitation System (LIPS)
  15. Gene expression analysis of embryonic pancreas development master regulators and terminal cell fate markers in resected pancreatic cancer: A correlation with clinical outcome
  16. Pluripotent stem cell replacement approaches to treat type 1 diabetes
  17. Recommendations from the United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis
  18. Undiagnosed prediabetes is highly prevalent in primary infertile men - results from a cross-sectional study
  19. Differentiation of Sendai virus-reprogrammed iPSC into β cells, compared with human pancreatic islets and immortalized β cell line
  20. Study of 2009 H1N1 Pandemic Influenza Virus as a Possible Causative Agent of Diabetes
  21. Defining Outcomes for β-cell Replacement Therapy in the Treatment of Diabetes
  22. Regenerative Medicine and Diabetes: Targeting the Extracellular Matrix Beyond the Stem Cell Approach and Encapsulation Technology
  23. The effects of kisspeptin on β-cell function, serum metabolites and appetite in humans
  24. Report of the Key Opinion Leaders Meeting on Stem Cell-derived Beta Cells
  25. Four-class tumor staging for early diagnosis and monitoring of murine pancreatic cancer using magnetic resonance and ultrasound
  26. No evidence of pancreatic ductal adenocarcinoma specific autoantibodies to Ezrin in a liquid phase LIPS immunoassay
  27. Targeting GLP-1 receptor trafficking to improve agonist efficacy
  28. The first 142 amino acids of glutamate decarboxylase do not contribute to epitopes recognized by autoantibodies associated with Type 1 diabetes
  29. Insulin-mimetic effects of short-term rapamycin in type 1 diabetic patients prior to islet transplantation
  30. The role of neutrophil-to-lymphocyte ratio in men with erectile dysfunction-preliminary findings of a real-life cross-sectional study
  31. Allo- and auto-percutaneous intra-portal pancreatic islet transplantation (PIPIT) for diabetes cure and prevention: the role of imaging and interventional radiology
  32. Defining outcomes for β-cell replacement therapy in the treatment of diabetes: a consensus report on the Igls criteria from the IPITA/EPITA opinion leaders workshop
  33. Defining outcomes for beta cell replacement therapy: a work in progress
  34. Detection and Characterization of CD8+Autoreactive Memory Stem T Cells in Patients With Type 1 Diabetes
  35. The potential and challenges of alternative sources of β cells for the cure of type 1 diabetes
  36. Proceedings of the signature series event of the international society for cellular therapy: “Advancements in cellular therapies and regenerative medicine in digestive diseases,” London, United Kingdom, May 3, 2017
  37. Anti-Inflammatory Strategies in Intrahepatic Islet Transplantation
  38. A novel LIPS assay for insulin autoantibodies
  39. Minimally Invasive Pancreatectomy plus Islet Autotransplantation for Benign Tumors of the Pancreatic Neck and Body
  40. A Targeted RNAi Screen Identifies Endocytic Trafficking Factors That Control GLP-1 Receptor Signaling in Pancreatic β-Cells
  41. MiR‐184 expression is regulated by AMPK in pancreatic islets
  42. Bioengineering the Pancreas: Cell-on-Scaffold Technology
  43. Glucocorticoids Reprogram β-Cell Signaling to Preserve Insulin Secretion
  44. Integrating T cell metabolism in cancer immunotherapy
  45. miR-204 is associated with an endocrine phenotype in human pancreatic islets but does not regulate the insulin mRNA through MAFA
  46. A preoperative score to predict early death after pancreatic cancer resection
  47. Autoantibody binding in liquid phase to IL-2 in human sera is not type 1 diabetes specific
  48. Immunological Issues After Stem Cell-Based β Cell Replacement
  49. Modeling the Iatrogenic Pancreatic Cancer Risk After Islet Autotransplantation in Mouse
  50. Pancreatic Islet Transplantation Technologies: State of the Art of Micro- and Macro-Encapsulation
  51. Corrigendum: Advances in pancreatic islet monolayer culture on glass surfaces enable super-resolution microscopy and insights into beta cell ciliogenesis and proliferation
  52. Insulin-mimetic effects of short-term Rapamycin in type 1 diabetic patients prior islet transplantation
  53. Role of Extracellular vesicles in the crosstalk between adipocytes and pancreatic beta-cells
  54. Transplant Site Influences the Immune Response After Islet Transplantation
  55. Advances in pancreatic islet monolayer culture on glass surfaces enable super-resolution microscopy and insights into beta cell ciliogenesis and proliferation
  56. MP81-15 THE ROLE OF NEUTROPHIL-TO-LYMPHOCYTE RATIO IN MEN WITH ERECTILE DYSFUNCTION – PRELIMINARY FINDINGS OF A REAL-LIFE CROSS-SECTIONAL STUDY
  57. MP81-20 THE ROLE OF SYSTEMIC INFLAMMATION IN DETERMINING HEALTH STATUS IN MEN WITH SEXUAL DYSFUNCTION – A WORRISOME SCENARIO IN YOUNG MEN
  58. PD13-07 MEN WITH INSULIN RESISTANCE ARE AT INCREASED RISK OF AZOOSPERMIA: RESULTS FROM A CROSS-SECTIONAL STUDY
  59. Salvage Islet Auto Transplantation After Relaparatomy
  60. Stem cells to restore insulin production and cure diabetes
  61. Human Pancreatic β Cell lncRNAs Control Cell-Specific Regulatory Networks
  62. Luminescent Immunoprecipitation System (LIPS) for Detection of Autoantibodies Against ATP4A and ATP4B Subunits of Gastric Proton Pump H+,K+-ATPase in Atrophic Body Gastritis Patients
  63. Duodenal Mucosa of Patients With Type 1 Diabetes Shows Distinctive Inflammatory Profile and Microbiota
  64. United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU)
  65. Establishment, characterization and long-term culture of human endocrine pancreas-derived microvascular endothelial cells
  66. MicroRNA expression profiles of human iPSCs differentiation into insulin-producing cells
  67. Human pancreatic β cell lncRNAs control cell-specific regulatory networks
  68. Abstract A07: Identification of endocrine/metabolic biomarkers associated to early PDC in a transgenic mouse model
  69. Ultra-marathon 100 km in an islet-transplanted runner
  70. Primary Human and Rat β-Cells Release the Intracellular Autoantigens GAD65, IA-2, and Proinsulin in Exosomes Together With Cytokine-Induced Enhancers of Immunity
  71. Effect of Diabetes on Survival after Resection of Pancreatic Adenocarcinoma. A Prospective, Observational Study
  72. Coxsackie–adenovirus receptor expression is enhanced in pancreas from patients with type 1 diabetes
  73. IL-7 Mediated Homeostatic Expansion of Human CD4+CD25+FOXP3+ Regulatory T Cells After Depletion With Anti-CD25 Monoclonal Antibody
  74. Beta Cell Hubs Dictate Pancreatic Islet Responses to Glucose
  75. Diabetes associated with pancreatic ductal adenocarcinoma is just diabetes: Results of a prospective observational study in surgical patients
  76. Insulin resistance is associated with the aggressiveness of pancreatic ductal carcinoma
  77. Single-centre experience of extending indications for percutaneous intraportal islet autotransplantation (PIPIAT) after pancreatic surgery to prevent diabetes: feasibility, radiological aspects, complications and clinical outcome
  78. V-Maf Musculoaponeurotic Fibrosarcoma Oncogene Homolog A Synthetic Modified mRNA Drives Reprogramming of Human Pancreatic Duct-Derived Cells Into Insulin-Secreting Cells
  79. The Human Pancreas as a Source of Protolerogenic Extracellular Matrix Scaffold for a New-generation Bioartificial Endocrine Pancreas
  80. Identification of Tetraspanin-7 as a Target of Autoantibodies in Type 1 Diabetes
  81. Autologous Islet Transplantation in Patients Requiring Pancreatectomy: A Broader Spectrum of Indications Beyond Chronic Pancreatitis
  82. Islet Volume and Indexes of β-Cell Function in Humans
  83. The state of the art of islet transplantation and cell therapy in type 1 diabetes
  84. Sorcin Links Pancreatic β-Cell Lipotoxicity to ER Ca2+Stores
  85. Phase II trial of salvage therapy with trabectedin in metastatic pancreatic adenocarcinoma
  86. Enterovirus strain and type-specific differences in growth kinetics and virus-induced cell destruction in human pancreatic duct epithelial HPDE cells
  87. Gemcitabine-releasing mesenchymal stromal cells inhibit in vitro proliferation of human pancreatic carcinoma cells
  88. MR Imaging Monitoring of Iron-Labeled Pancreatic Islets in a Small Series of Patients: Islet Fate in Successful, Unsuccessful, and Autotransplantation
  89. (Ir)relevance of Metformin Treatment in Patients with Metastatic Pancreatic Cancer: An Open-Label, Randomized Phase II Trial
  90. The CXCR1/2 Pathway: Involvement in Diabetes Pathophysiology and Potential Target for T1D Interventions
  91. Hepatic steatosis after islet transplantation: Can ultrasound predict the clinical outcome? A longitudinal study in 108 patients
  92. Islet autotransplantation as a safe procedure in patients with malignancy
  93. Monitoring Inflammation, Humoral and Cell-mediated Immunity in Pancreas and Islet Transplants
  94. Creation and implantation of acellular rat renal ECM-based scaffolds
  95. Characterization of pancreatic NMDA receptors as possible drug targets for diabetes treatment
  96. Human induced pluripotent stem cells differentiate into insulin-producing cells able to engraft in vivo
  97. Dual-Modal Magnetic Resonance/Fluorescent Zinc Probes for Pancreatic β-Cell Mass Imaging
  98. Diabetes After Pancreatic Surgery: Novel Issues
  99. Human islet distribution programme for basic research: activity over the last 5 years
  100. Calcineurin Inhibitor-Free Immunosuppressive Regimen in Type 1 Diabetes Patients Receiving Islet Transplantation
  101. β-Cell Differentiation of Human Pancreatic Duct–Derived Cells AfterIn VitroExpansion
  102. CXCR1/2 Inhibition Blocks and Reverses Type 1 Diabetes in Mice
  103. Isolation, Characterization and Potential Role in Beta Cell-Endothelium Cross-Talk of Extracellular Vesicles Released from Human Pancreatic Islets
  104. Clinical signature and pathogenetic factors of diabetes associated with pancreas disease (T3cDM): a prospective observational study in surgical patients
  105. Autologous Islet Transplantation in Patients Requiring Pancreatectomy for Neoplasm
  106. The role of insulin in tumor recurrence after resection for pancreatic malignancy. Results of a prospective study
  107. Engraftment Versus Immunosuppression
  108. ADCY5 Couples Glucose to Insulin Secretion in Human Islets
  109. RFamide Peptides 43RFa and 26RFa Both Promote Survival of Pancreatic  -Cells and Human Pancreatic Islets but Exert Opposite Effects on Insulin Secretion
  110. The allocation of pancreas allografts on donor age and duration of intensive care unit stay: the experience of the North Italy Transplant program
  111. Pancreatic islet enhancer clusters enriched in type 2 diabetes risk-associated variants
  112. Lysine deacetylase inhibition prevents diabetes by chromatin-independent immunoregulation and β-cell protection
  113. Relaparotomy for a pancreatic fistula after a pancreaticoduodenectomy: a comparison of different surgical strategies
  114. Combined laparoscopic spleen-preserving distal pancreatectomy and islet autotransplantation for benign pancreatic neoplasm
  115. Effects of exercise in a islet-transplanted half-marathon runner: outcome on diabetes management, training and metabolic profile
  116. Autologous Pancreatic Islet Transplantation in Human Bone Marrow. Diabetes 2013;62:3523-3531
  117. Liver Perfusion Changes Occurring During Pancreatic Islet Engraftment: A Dynamic Contrast-Enhanced Magnetic Resonance Study
  118. Human Pancreatic Islet Preparations Release HMGB1: (Ir)Relevance for Graft Engraftment
  119. β-cell transplantation in diabetes mellitus
  120. Rapamycin unbalances the polarization of human macrophages to M1
  121. Islet Transplantation Stabilizes Hemostatic Abnormalities and Cerebral Metabolism in Individuals With Type 1 Diabetes
  122. Lipotoxicity disrupts incretin-regulated human β cell connectivity
  123. Anti-Inflammatory Strategies to Enhance Islet Engraftment and Survival
  124. Extending Indications for Islet Autotransplantation in Pancreatic Surgery
  125. Autologous Pancreatic Islet Transplantation in Human Bone Marrow
  126. A phase II trial of second-line therapy with trabectedin in metastatic pancreatic adenocarcinoma (mPA)
  127. Mass spectrometric analysis reveals O-methylation of pyruvate kinase from pancreatic cancer cells
  128. Pharmacological inhibition of Eph receptors enhances glucose-stimulated insulin secretion from mouse and human pancreatic islets
  129. Ectopic expression of the heterotrimeric G15 protein in pancreatic carcinoma and its potential in cancer signal transduction
  130. Murine animal models for preclinical islet transplantation
  131. Reduction of Circulating Neutrophils Precedes and Accompanies Type 1 Diabetes
  132. Homeostatic T Cell Proliferation after Islet Transplantation
  133. Alloantibody and Autoantibody Monitoring Predicts Islet Transplantation Outcome in Human Type 1 Diabetes
  134. Autologous islet transplantation to improve glycaemic control following extended pancreatectomy: indications and outcome
  135. Immunomodulation of CXCR2 Improves the Islet Engraftment and Survival after Liver Infusion
  136. Influenza A Viruses Grow in Human Pancreatic Cells and Cause Pancreatitis and Diabetes in an Animal Model
  137. Association of exercise-induced hyperinsulinaemic hypoglycaemia with MCT1-expressing insulinoma
  138. CXCR1/2 inhibition enhances pancreatic islet survival after transplantation
  139. Human β Cell Transcriptome Analysis Uncovers lncRNAs That Are Tissue-Specific, Dynamically Regulated, and Abnormally Expressed in Type 2 Diabetes
  140. Enterovirus-induced gene expression profile is critical for human pancreatic islet destruction
  141. MS analysis reveals O-methylation of L-lactate dehydrogenase from pancreatic ductal adenocarcinoma cells
  142. No evidence of enteroviruses in the intestine of patients with type 1 diabetes
  143. Age- and diet-dependent requirement of DJ-1 for glucose homeostasis in mice with implications for human type 2 diabetes
  144. Gene Signatures Associated with Mouse Postnatal Hindbrain Neural Stem Cells and Medulloblastoma Cancer Stem Cells Identify Novel Molecular Mediators and Predict Human Medulloblastoma Molecular Classification
  145. Des-Acyl Ghrelin Fragments and Analogues Promote Survival of Pancreatic β-Cells and Human Pancreatic Islets and Prevent Diabetes in Streptozotocin-Treated Rats
  146. Proteomic Analysis Reveals Warburg Effect and Anomalous Metabolism of Glutamine in Pancreatic Cancer Cells
  147. Insulin resistance/hyperinsulinemia and cancer mortality: the Cremona study at the 15th year of follow-up
  148. Comparative Evaluation of Simple Indices of Graft Function After Islet Transplantation
  149. Expansion of Th17 Cells and Functional Defects in T Regulatory Cells Are Key Features of the Pancreatic Lymph Nodes in Patients With Type 1 Diabetes
  150. Alternative Transplantation Sites for Pancreatic Islet Grafts
  151. Therapeutic plasticity of stem cells and allograft tolerance
  152. Fatty liver index and mortality: The cremona study in the 15th year of follow-up
  153. Proteomic Analysis of Pancreatic Ductal Adenocarcinoma Cells Reveals Metabolic Alterations
  154. Ask The Experts: Challenges and prospects for stem cell-based therapy in Type 1 diabetes
  155. Phosphoproteomic Analysis of Pancreatic Ductal Adenocarcinoma Cells Reveals Differential Phosphorylation of Cell Adhesion, Cell Junction and Structural Proteins
  156. Risks and Benefits of Transplantation in the Cure of Type 1 Diabetes: Whole Pancreas Versus Islet Transplantation. A Single Center Study
  157. Bone Marrow and Pancreatic Islets: An Old Story With New Perspectives
  158. Beta cell function during rapamycin monotherapy in long-term type 1 diabetes
  159. Prevalence, Metabolic Features, and Prognosis of Metabolically Healthy Obese Italian Individuals: The Cremona Study
  160. Cellular tropism of human enterovirus D species serotypes EV-94, EV-70, and EV-68 in vitro: Implications for pathogenesis
  161. Role of CCL2/MCP-1 in Islet Transplantation
  162. ISLET CELL TRANSPLANTS FAIL DUE TO DONOR SPECIFIC ANTIBODIES
  163. Mass Spectrometry Analysis of the Post-Translational Modifications of α-Enolase from Pancreatic Ductal Adenocarcinoma Cells
  164. Co-Graft of Allogeneic Immune Regulatory Neural Stem Cells (NPC) and Pancreatic Islets Mediates Tolerance, while Inducing NPC-Derived Tumors in Mice
  165. Molecular mechanisms of perineural invasion, a forgotten pathway of dissemination and metastasis
  166. Mesenchymal cells appearing in pancreatic tissue culture are bone marrow-derived stem cells with the capacity to improve transplanted islet function
  167. A Photoprotein in Mouse Embryonic Stem Cells Measures Ca2+ Mobilization in Cells and in Animals
  168. Pancreatic Endocrine Tumors: Expression Profiling Evidences a Role for AKT-mTOR Pathway
  169. Modulation of Early Inflammatory Reactions to Promote Engraftment and Function of Transplanted Pancreatic Islets in Autoimmune Diabetes
  170. Mesenchymal Stem Cells as Feeder Cells for Pancreatic Islet Transplants
  171. The Pancreatic Lymph-nodes of Type 1 Diabetic Patients Contain Epigenetically-imprinted Natural Regulatory T Cells which Lack Suppressive Function
  172. Improving the Procedure for Detection of Intrahepatic Transplanted Islets by Magnetic Resonance Imaging
  173. Bone marrow as an alternative site for islet transplantation
  174. Association Between Plasma Monocyte Chemoattractant Protein-1 Concentration and Cardiovascular Disease Mortality in Middle-Aged Diabetic and Nondiabetic Individuals
  175. Rapamycin does not adversely affect intrahepatic islet engraftment in mice and improves early islet engraftment in humans
  176. The contribution of hematopoietic stem cells to beta-cell replacement
  177. Mesenchymal Cells Appearing in Pancreatic Tissue Culture are Bone Marrow-Derived Stem Cells With the Capacity to Improve Transplanted Islet Function
  178. Ghrelin-producing epsilon cells in the developing and adult human pancreas
  179. Intrahepatic Islet Transplant in the Mouse: Functional and Morphological Characterization
  180. The Chemokine Receptor CX3CR1 Is Involved in the Neural Tropism and Malignant Behavior of Pancreatic Ductal Adenocarcinoma
  181. β-cell transplantation for diabetes therapy
  182. Rapamycin Monotherapy in Patients With Type 1 Diabetes Modifies CD4+CD25+FOXP3+ Regulatory T-Cells
  183. High Levels of Donor CCL2/MCP-1 Predict Graft-Related Complications and Poor Graft Survival After Kidney-Pancreas Transplantation
  184. Diabetes mellitus: an opportunity for therapy with stem cells?
  185. Islet transplantation in patients with autoimmune diabetes induces homeostatic cytokines that expand autoreactive memory T cells
  186. Transplant Estimated Function: A simple index to evaluate  -cell secretion after islet transplantation
  187. A preclinical evaluation of pemetrexed and irinotecan combination as second-line chemotherapy in pancreatic cancer
  188. Relevance of Hyperglycemia on the Timing of Functional Loss of Allogeneic Islet Transplants: Implication for Mouse Model
  189. Culture Medium Modulates Proinflammatory Conditions of Human Pancreatic Islets Before Transplantation
  190. Increased intestinal permeability precedes clinical onset of type 1 diabetes
  191. Differential Effects of Immunosuppressive Drugs on Chemokine Receptor CCR7 in Human Monocyte-Derived Dendritic Cells: Selective Upregulation by Rapamycin
  192. Rapamycin Induces a Caspase-Independent Cell Death in Human Monocytes
  193. Stem Cells and the Kidney: A New Therapeutic Tool?
  194. Raltitrexed–eloxatin salvage chemotherapy in gemcitabine-resistant metastatic pancreatic cancer
  195. Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets
  196. Increased Survival, Proliferation, and Migration in Metastatic Human Pancreatic Tumor Cells Expressing Functional CXCR4
  197. Donor and Isolation Variables Associated with Human Islet Monocyte Chemoattractant Protein-1 Release
  198. Tissue Factor and CCL2/Monocyte Chemoattractant Protein-1 Released by Human Islets Affect Islet Engraftment in Type 1 Diabetic Recipients
  199. A comprehensive in vitro characterization of pancreatic ductal carcinoma cell line biological behavior and its correlation with the structural and genetic profile
  200. Tumor-Derived MUC1 Mucins Interact with Differentiating Monocytes and Induce IL-10highIL-12low Regulatory Dendritic Cell
  201. In vitro modulation of monocyte chemoattractant protein-1 release in human pancreatic islets
  202. From Pattern Recognition Receptor to Regulator of Homeostasis: The Double-Faced Macrophage Mannose Receptor
  203. Cross-Linking of the Mannose Receptor on Monocyte-Derived Dendritic Cells Activates an Anti-Inflammatory Immunosuppressive Program
  204. Fasting Plasma Leptin, Tumor Necrosis Factor-  Receptor 2, and Monocyte Chemoattracting Protein 1 Concentration in a Population of Glucose-Tolerant and Glucose-Intolerant Women: Impact on cardiovascular mortality
  205. Effects of anti-lymphocytes and anti-thymocytes globulin on human dendritic cells
  206. Rapamycin impairs antigen uptake of human dendritic cells1
  207. Strategies for tumor immune escape
  208. Human Pancreatic Islets Produce and Secrete MCP-1/CCL2: Relevance in Human Islet Transplantation
  209. Generation and functional characterisation of dendritic cells from patients with pancreatic carcinoma with special regard to clinical applicability
  210. Vitamin D3 Affects Differentiation, Maturation, and Function of Human Monocyte-Derived Dendritic Cells
  211. EFFECTS OF CRYOPRESERVATION ON IN VITRO AND IN VIVO LONG-TERM FUNCTION OF HUMAN ISLETS1
  212. CRYOPRESERVATION OF HUMAN ISLETS OF LANGERHANS
  213. Glucocorticoids increase the endocytic activity of human dendritic cells
  214. Interleukin-10 increases mannose receptor expression and endocytic activity in monocyte-derived dendritic cells
  215. IL-10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages
  216. Islet transplantation in IDDM patients
  217. Glucagon improves insulin secretion from pig islets in vitro
  218. Isolation and function of adult pig Islets
  219. Gluten-Free Diet in Subjects at Risk for Type 1 Diabetes: A Tool for Delaying Progression to Clinical Disease?